Medium-/Long-Term Effects of a Specific Exercise Protocol Combined with Patient Education on Spine Mobility, Chronic Fatigue, Pain, Aerobic Fitness and Level of Disability in Fibromyalgia

Table 4

Rheumatological evaluation results.

	Groups	T0 (mean ± SD)	T1 (mean ± SD)	T6 (mean ± SD)	P (T0-T1)	P (T0–T6)
Pain (VAS, 0–10)	EG	6.10±2.07	5.25±2.47	5.80±1.99	ns	ns
	CG	6.08±1.62	5.50±2.43	5.42±2.87	ns	ns
Sleep disorders (VAS, 0–10)	EG	6.8±2.65	4.6±3.14	6.3±2.99	0.007	0.056
	CG	6.92±3.53	5.00±3.05	6.08±3.42	ns	ns
Stiffness (VAS, 0–10)	EG	7.50±1.7	6.40±2.56	6.85±1.57	0.013	0.022
	CG	8.00±1.21	6.67±0.89	6.17±2.59	ns	ns
Weariness (VAS, 0–10)	EG	7.70±1.87	6.15±2.58	7.05±1.93	ns	ns
	CG	7.58±2.75	7.58±2.23	7.08±1.88	ns	ns
FIQ (0–100)	EG	62.66±14.42	55.45±12.20	48.75±17.43	0.056	ns
	CG	59.09±15.63	50.92±19.96	56.94±14.47	ns	ns
FAS (0–10)	EG	6.61±1.61	5.25±1.86	6.17±1.67	0.026	ns
	CG	6.42±2.08	5.98±1.55	5.73±2.23	ns	ns
TPC (0–18)	EG	12.70±4.65	9.35±5.02	9.55±5.45	0.034	0.054
	CG	13.67±4.50	11.83±5.77	12.17±5.77	ns	ns

SD: standard deviation; EG: experimental group; CG: control group; VAS: visual analogue scale; FIQ: Fibromyalgia Impact Questionnaire; FAS: Fibromyalgia Assessment Status; TPC: tender point count; ns: nonsignificant.
In bold: statistically significant values.